Table 1 Baseline characteristics.

From: Citrate pharmacokinetics in critically ill liver failure patients receiving CRRT

Patient

Age/sex

Admission diagnosis

Cause of AKI

Cause of cirrhosis

Cause of ALF

APACHE II score

SOFA score

Survival status

1

47/M

Post heart transplantation

Cardiorenal syndrome

None

Ischemic hepatitis

16

16

Alive

2

67/F

Scleroderma renal crisis

Sepsis AKI

None

Ischemic hepatitis

19

18

Death

3

53/M

Chikungunya viral infection

Sepsis AKI

None

Ischemic hepatitis

16

13

Alive

4

68/M

Upper GI bleeding

Ischemic ATN

None

Ischemic hepatitis

18

12

Death

5

57/M

Pneumonia with septic shock

Sepsis AKI

None

Drug induced hepatitis

21

7

Death

6

46/M

Disseminated TB

Sepsis AKI

None

Drug induced hepatitis

28

17

Death

7

81/M

Drug induced hepatitis

Sepsis AKI

None

Drug induced hepatitis

19

13

Death

8

52/M

Massive upper GI bleeding

Hepatorenal syndrome

Alcoholic

Ischemic

20

16

Death

9

68/F

Cryoglobulinemia

Septic AKI

HBV

Ischemic

30

19

Death

10

53/F

PCP pneumonia

Septic AKI

Autoimmune hepatitis

Autoimmune

15

15

Death

11

97/M

Pneumonia with septic shock

Septic AKI

NASH

Ischemic

23

19

Death

12

85/M

Cardiogenic shock

Cardiorenal syndrome

Cardiac cirrhosis

Ischemic

22

11

Death

13

43/M

Pneumonia with septic shock

Septic AKI

HCV

Ischemic

30

11

Death

14

79/M

Primary bacteremia with septic shock

Septic AKI

NASH

Ischemic

28

18

Death

  1. AKI acute kidney injury, APACHE II score Acute Physiology and Chronic Health Evaluation II score, GI gastrointestinal, HBV hepatitis B virus, HCV hepatitis C virus, NASH non-alcoholic steatohepatitis; PCP, pneumocystis pneumonia, SOFA score Sequential Organ Failure Assessment score, TB tuberculosis.